TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Complete Virological response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of elevation of serum creatinine as a measure of renal safety
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Incidence of osteopenia and osteoporosis as a measure of bone safety
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: AUC of OPL-002
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of complete pathological responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Occurrence of non-hematologic toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Side-effects and adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Restoration of chin and lip sensation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Proportion of subjects with evidence of bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change in Childhood Autism Rating Scale (CARS2-HF) Value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Conners' Rating Scale - Revised (L) value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Psychological strain
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cognition (MATRICS Composite score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax: Maximum Observed Plasma Concentration of Alisertib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC(0-tau): Area Under the Plasma Concentration-time Curve From Time 0 to Time Tau Over the Dosing Interval for Alisertib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessment of quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change from baseline of the PANSS total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: skin to skin contact start time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Sensitivity of 18F-fluorocholine PET/CT and NaF PET/CT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of 18F-fluorocholine PET/CT and NaF PET/CT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 3-month Abstinence Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Polyp and adenoma detection rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Mass balance of total radioactivity excreted
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Total radioactivity concentrations in urine and feces
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Total radioactivity levels in blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Fugl-Meyer assessment (FMA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Simple Test for Evaluating Hand Function (STEF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Neonatal death ratio
Endpoint domain: Mortality/survival
Primary endpoint: Intrauterine death ratio
Endpoint domain: Mortality/survival
Primary endpoint: Abortion ratio
Endpoint domain: Mortality/survival
Primary endpoint: Change From Baseline in NRS Pain Intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in past 30 day drug misuse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in behaviors associated with drug misuse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction negative physical health, psychosocial health, and socioeconomic consequences
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Hematologic improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change From Baseline in Hemoglobin Level at Week 4
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Number of Participants With Composite Events of Death, Myocardial Infarction and Cerebrovascular Accident, Serious Events of Unstable Angina, Transient Ischemic Attack, Arrythmia and Congestive Heart Failure, Peripheral Thrombo-embolic Events
Endpoint domain: Mortality/survival
Primary endpoint: Number of Participants With Confirmed, Treatment Emergent Antibodies to MK2578
Endpoint domain: Adverse events/effects
Primary endpoint: Benchmark Acceptability Rate
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: epicardial and myocardial flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Treatment-induced myelosuppression (e.g., neutropenia)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Maximum tolerated dose (MTD) of CAR T cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of general toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of All Participants Negative for Viral RNA on Day 5
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Reactive hyperemia index (RHI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Monthly Heavy Drinking Days
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean TCS in mV
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of prescription opioids used postoperatively
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Prevalence of Primary Biliary Cholangitis (PBC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hematology
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Self-reported Intake of Fruit and Vegetables (Number of Portions Per Day)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Markers of Airway Inflammation in Induced Sputum - Sputum 8-isoprostane
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of Participants Classified as Responders and Non-responders for Objective Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cardiac index (l/min/m2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: incidence of endoscopic mild mucosal injury
Endpoint domain: Adverse events/effects
Primary endpoint: arterial blood oxygen partial pressure (PaO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Seat belt knowledge
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: amount of regenerated bone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: functional event-free primary patency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Renal Clearance of Metformin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Scores on unified MSA rating scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Salivary Alpha Amylase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Salivary Cortisol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of Nicotine Transdermal Patch in CIPN
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Neck Collar Size
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessment of vascular anatomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Mean Time Post-blink to 15% Distortion of the Projected Rings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of cancers related to smoking, diet or body mass index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Breast Cancer Worry Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Duration of response (DOR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HAMD/MARS score reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Zolpidem pharmacokinetic measures (Cmax, Tmax, t1/2, AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Global sleep parameters
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Change in Orthodontic Pain Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Abdominal Tissue Oxygenation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Iron deposition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Emotional availability
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Amount of PCA-administered morphine consumed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum acetaminophen levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Midline Localization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Supraventricular, ventricular and total Extrasystoles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Finding radioactive node in zone D
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Physiological reaction to noxious stimulus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to First Achieve Initial Prespecified SBP Target Range
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage to First Achieve Initial Prespecified SBP Target Range
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change from Baseline in FDG-PET Metabolic Measure of SUVR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants with Treatment-Emergent Adverse Events (TEAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants who have Suicidal Ideation or Behaviours
Endpoint domain: Adverse events/effects
Primary endpoint: Post LPS sputum neutrophil %
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Adverse events/serious adverse events (AEs/SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Ratio between plasma glucose level and glucose concentration at subcutaneous insulin delivery site
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percent Detection of Right to Left Shunt (RLS)/Patent Foramen Ovale (PFO)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Area under the somapacitan serum concentration time curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum serum concentration of somapacitan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: index of Toe and Finger Ischemia (iTFI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Circulatory outcomes
Primary endpoint: Number and percentage of seroconverted participants at 28 days post vaccination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Geometric Mean Titers (GMTs) of serum HI antibodies at baseline (Day 0) and post- vaccination (Day 28)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Response Rate to Sorafenib
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: QTcI - QT Interval Individually Corrected for Heart Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in left ventricular size
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of Primary Care Centers and professionals using EHR
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percentage of professionals using Forced Spirometry in EHR
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in number of FS tests included in EHR
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change of motivation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change of care burden
Endpoint domain: Resource use
Endpoint subdomain: Societal/carer burden
Primary endpoint: Change in Defense and Veterans Pain Rating Scale (DVPRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Patient and Observer Scar Assessment Scale (POSAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average SUVmax of Ga68 PSMA Uptake Outside the Expected Normal Biodistribution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average SUVmean of Ga68 PSMA Uptake Outside the Expected Normal Biodistribution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average SUVmax Focal Uptake of Ga68 PSMA (F/N Ratio)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average SUVmean Focal Uptake of Ga68 PSMA (F/N Ratio)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Cerebral Blood Flow (CBF) as Determined by MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cerebrovascular outcomes
Primary endpoint: Renal tubular function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: short term neurobehavioral outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Electroencephalography (EEG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Gait speed analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Heart rate variability (HRV) indices SDNN and RMSSD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of Participants Who Achieved Treatment Goal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wisconsin Upper Respiratory Symptom Survey-21 (WURSS-21) score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Blood levels of AZD6140
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Percent Platelet Aggregation Induced by Arachidonic Acid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Percent Platelet Aggregation Induced by Collagen
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: End of study Hb level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Geometric Mean Titers (GMTs) of Influenza Vaccine Antibodies at Day 0
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of Participants Achieving Seroconversion Against Influenza Virus Antigens
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of Participants With Serious Adverse Events (SAEs) Including Adverse Event of Special Interest (AESIs)
Endpoint domain: Adverse events/effects
Primary endpoint: Composite outcome of death or ICU admission or mechanical ventilation
Endpoint domain: Mortality/survival
Primary endpoint: Excessive Weight Loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of retrieved oocytes by COH based on Per stage approach
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Unlabeled (Unexpected) Adverse Drug Reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Pain during the active phase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Memory function assessment
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Moderate or Severe Hypothermia at discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of subjects with Breakthrough pain
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants Reporting Injection Site Reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants Reporting Systemic Reactions
Endpoint domain: Adverse events/effects
Primary endpoint: VAS pain scoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: overall weight gain during pregnancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: proportion of participants exceeding weight gain above IOM recommendations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Suspected and Pre-E cases
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient Days in the Community
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Proportion of subjects in sustained response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of Parkinson's related genetic mutations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood pressure reactivity to mental stress
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of Patients Experiencing at Least One Adverse Event (AE)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of Patients Experiencing AEs That Resulted in Discontinuation of Investigational Product (IP)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of Patients Experiencing Severe Adverse Events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: GI Side Effects as Assessed by Gastro Intestinal Symptoms Rating Scale (GSRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Number of Participants With Bone Marrow Suppression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Incidence of Cytomegalovirus Infection or Disease During the Study Period
Endpoint domain: Adverse events/effects
Primary endpoint: Successful monitoring of continuing pregnancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Change in Fertility knowledge
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Major cardiovascular adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Device Success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage Change From Baseline in Tumour Size
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Seroprotection against Influenza B
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Seroprotection against Influenza H1N1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Seroprotection against Influenza H3N2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Plasma and urine benzo[a]pyrene and metabolite levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vascular Dementia Assessment Scale-cognitive Subscale (VaDAS-cog)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Alzheimer's Disease Cooperative Study-clinical Global Impression of Change (ADCS-CGIC)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Bone Fusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Severity of Psychopathological symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Falls, accidents, and injuries
Endpoint domain: Adverse events/effects
Primary endpoint: Change in WOMAC Pain Subscale
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: number of movements avoided the center
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Predictors of survival
Endpoint domain: Mortality/survival
Primary endpoint: Change of rating in Modified Rush Video Scale (MRVS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in rating of Yale Global Tic Severity Scale (YGTSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of rating in Adult Tic Questionnaire (ATQ)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of rating in Premonitory Urge for Tics Scale (PUTS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to disappearance of bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 4-month Progression-free Survival (PFS) Rate
Endpoint domain: Mortality/survival
Primary endpoint: Mean change of ESS score
Endpoint domain: Life impact
Endpoint subdomain: Sleep